Van Strum & Towne’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,591
Closed -$213K 114
2025
Q4
$213K Buy
+2,591
New +$202K 0.06% 112
2025
Q2
Sell
-2,591
Closed -$209K 113
2025
Q1
$209K Sell
2,591
-10
-0.4% -$859 0.07% 109
2024
Q4
$203K Sell
2,601
-14
-0.5% -$1.19K 0.07% 105
2024
Q3
$245K Hold
2,615
0.09% 97
2024
Q2
$204K Hold
2,615
0.07% 102
2024
Q1
$238K Sell
2,615
-107
-4% -$8.9K 0.09% 99
2023
Q4
$210K Buy
+2,722
New +$191K 0.08% 99
2023
Q3
Sell
-2,772
Closed -$225K 96
2023
Q2
$225K Hold
2,772
0.09% 92
2023
Q1
$227K Buy
+2,772
New +$198K 0.1% 89

Other funds holding GEHC

Van Strum & Towne's GEHC Position: Q1 2026 in Review

Van Strum & Towne sold out of GE HealthCare (GEHC) in Q1 2026, closing a stake of 2,591 shares — an estimated $213K sold.

Van Strum & Towne first reported a position in GEHC in Q1 2023 and held it in 9 quarters. The position peaked at $245K in Q3 2024. 1,265 funds tracked by Wall St. Rank hold GEHC as of Q1 2026.

  • Van Strum & Towne reported no remaining GE HealthCare position as of Q1 2026 after selling out during the quarter.
  • Van Strum & Towne sold 2,591 GE HealthCare shares in Q1 2026, an estimated $213K.
  • Van Strum & Towne first reported a position in GE HealthCare in Q1 2023 and held it in 9 quarters.
  • Van Strum & Towne's GE HealthCare position peaked at $245K in Q3 2024.
  • 1,265 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2026.

Based on Van Strum & Towne's 13F filing for Q1 2026, filed 7 May 2026.